Abcellera Biologics Inc
F:8QQ

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
F:8QQ
Watchlist
Price: 3.672 EUR -0.65% Market Closed
Market Cap: 1.1B EUR
Section:
 

Relative Value

The Relative Value of one 8QQ stock under the Base Case scenario is hidden EUR. Compared to the current market price of 3.672 EUR, Abcellera Biologics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

8QQ Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

37
P/S
P/S
Price to Sales
37
vs History
12
vs Industry
8
Median 3Y
27
Median 5Y
17
Industry
4.3
Forward
36.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
41
Median 3Y
-7.2
Median 5Y
-5
Industry
33.8
Forward
-6.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
1
Median 3Y
-9
Median 5Y
8.4
Industry
20.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
32
Median 3Y
-6.7
Median 5Y
-3.8
Industry
27.4
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
58
vs Industry
83
Median 3Y
1.2
Median 5Y
1.6
Industry
3
More Details
23
EV/S
EV/S
Enterprise Value to Sales
23
vs History
7
vs Industry
45
Median 3Y
8.1
Median 5Y
7.4
Industry
4.3
Forward
22.4
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.7
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
49
Median 3Y
-2.2
Median 5Y
-0.5
Industry
19.7
Forward
-3.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
44
Median 3Y
-2
Median 5Y
-0.6
Industry
25.5
Forward
-3.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
5
Median 3Y
-2.2
Median 5Y
5.3
Industry
20.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
35
Median 3Y
-3.2
Median 5Y
0
Industry
28.3
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
60
vs Industry
89
Median 3Y
0.8
Median 5Y
1.6
Industry
2.5
More Details

Multiples Across Competitors

8QQ Competitors Multiples
Abcellera Biologics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Abcellera Biologics Inc
F:8QQ
1.3B EUR 37 -7.6 -3.4 -3.1
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 403.6 4 781.9 1 402.4 2 817.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
233.7B USD 5.3 35.6 25.2 32.6
US
Danaher Corp
NYSE:DHR
168.4B USD 6.9 48.1 25.7 38.9
CH
Lonza Group AG
SIX:LONN
38B CHF 5.4 51.8 39.4 39.4
US
Agilent Technologies Inc
NYSE:A
42.1B USD 6.1 32.3 24.9 29.7
US
IQVIA Holdings Inc
NYSE:IQV
41.3B USD 2.6 32.2 15.4 23.1
CN
WuXi AppTec Co Ltd
SSE:603259
283.4B CNY 6.4 18.9 21.5 21.5
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
30.3B USD 7.7 36.3 26.1 29
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.9B EUR 7.1 78.8 28 46
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Abcellera Biologics Inc
F:8QQ
Average EV/EBITDA: 162.6
Negative Multiple: -3.4 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 402.4
5%
280.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.2
6%
4.2
US
Danaher Corp
NYSE:DHR
25.7
5%
5.1
CH
Lonza Group AG
SIX:LONN
39.4
18%
2.2
US
Agilent Technologies Inc
NYSE:A
24.9
13%
1.9
US
IQVIA Holdings Inc
NYSE:IQV
15.4
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
21.5
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
26.1
4%
6.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
28
19%
1.5

See Also

Summary
8QQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
8QQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
8QQ stock valuation using valuation multiples.
Wall Street Estimates
8QQ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
8QQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.